Teachers Advisors’s Adamas Pharmaceuticals ADMS Stock Holding History

Teachers Advisors’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$434K	Hold	61,024	–	–	﹤0.01%	2595
2018 Q4	$521K	Hold	61,024	–	–	﹤0.01%	2494
2018 Q3	$1.22M	Buy	61,024 +24,859	+69%	+$584K	﹤0.01%	2214
2018 Q2	$934K	Buy	36,165 +9,386	+35%	+$260K	﹤0.01%	2364
2018 Q1	$640K	Hold	26,779	–	–	﹤0.01%	2419
2017 Q4	$908K	Hold	26,779	–	–	﹤0.01%	2288
2017 Q3	$567K	Hold	26,779	–	–	﹤0.01%	2533
2017 Q2	$468K	Sell	26,779 -1,666	-6%	-$27.6K	﹤0.01%	2622
2017 Q1	$498K	Buy	28,445 +1,484	+6%	+$25.3K	﹤0.01%	2544
2016 Q4	$456K	Hold	26,961	–	–	﹤0.01%	2587
2016 Q3	$442K	Hold	26,961	–	–	﹤0.01%	2532
2016 Q2	$408K	Buy	26,961 +9,894	+58%	+$163K	﹤0.01%	2527
2016 Q1	$247K	Buy	17,067 +2,007	+13%	+$33.8K	﹤0.01%	2710
2015 Q4	$426K	Hold	15,060	–	–	﹤0.01%	2503
2015 Q3	$252K	Hold	15,060	–	–	﹤0.01%	2782
2015 Q2	$395K	Buy	15,060 +10,926	+264%	+$212K	﹤0.01%	2664
2015 Q1	$72K	Hold	4,134	–	–	﹤0.01%	3056
2014 Q4	$72K	Hold	4,134	–	–	﹤0.01%	3087
2014 Q3	$77K	Hold	4,134	–	–	﹤0.01%	3078
2014 Q2	$76K	Buy	+4,134	New	+$74.1K	﹤0.01%	3062

Other funds holding ADMS

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Teachers Advisors's ADMS Position: Q1 2019 in Review

Teachers Advisors held its Adamas Pharmaceuticals (ADMS) position steady in Q1 2019 at 61,024 shares worth $434K. The position accounts for ﹤0.01% of the portfolio, ranked #2595.

Teachers Advisors first reported a position in ADMS in Q2 2014 and has held it in 20 quarters since. The position peaked at $1.22M in Q3 2018. 99 funds tracked by Wall St. Rank hold ADMS as of Q1 2019.

Teachers Advisors held 61,024 shares of Adamas Pharmaceuticals worth $434K as of Q1 2019.
Teachers Advisors left its Adamas Pharmaceuticals share count unchanged in Q1 2019.
Adamas Pharmaceuticals made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2595 holding.
Teachers Advisors first reported a position in Adamas Pharmaceuticals in Q2 2014 and has held it in 20 quarters since.
Teachers Advisors's Adamas Pharmaceuticals position peaked at $1.22M in Q3 2018.
99 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.